Bloodstream Infections in Central Africa Caused by Strains of Salmonella Resistant to Nearly All Drugshttps://medicalxpress.com/news/2019-09-bloodstream-infections-central-africa-strains.htmlThe first extensively drug-resistant (XDR) strains of
Salmonella Typhimurium, a pathogen which is responsible for millions of bloodstream infections per year in sub-Saharan Africa, have been identified in the Democratic Republic of Congo (DRC). Drug-resistance has increased in successive groups of
S. Typhimurium over time. These new strains are resistant to all but one of the commonly available drugs in the DRC, with one sample showing reduced susceptibility to this final antibiotic.
Most Salmonella infections result in symptoms associated with food poisoning. While unpleasant, symptoms are not life-threatening in the vast majority of cases. But in sub-Saharan Africa, Salmonella such as S. Typhimurium can cause infections of the blood, known as invasive non-typhoidal Salmonella (iNTS) infections.
Every year, iNTS infections are estimated to affect 3.4 million people and result in 681,316 deaths globally, of which the majority are caused by S. Typhimurium. The containment and treatment of iNTS infections in places like the DRC is complicated by limited access to healthcare, infrastructure challenges and weakened immunity, with children under five years of age particularly at risk.
It is known that iNTS infections in sub-Saharan Africa are dominated by a type of S. Typhimurium known as ST313, which is associated with antibiotic resistance. Two groups of ST313 (named lineage I and II) split off independently and subsequently spread over the African continent. Antibiotic resistance has been growing over time, with lineage II now the primary cause of iNTS infections.
... "All antibiotic resistance genes contributing to "XDR' are present on the same plasmid. This is worrying because a plasmid is a mobile genetic element that could be transferred to other bacteria. While accumulating more antibiotic resistance, we discovered that the novel Salmonella Typhimurium line is also showing further genetic and behavioral changes which suggest ongoing evolution of the bacteria towards bloodstream infections."
Open Access: Sandra Van Puyvelde et al.
An African Salmonella Typhimurium ST313 sublineage with extensive drug-resistance and signatures of host adaptation,
Nature Communications (2019)
---------------------
Antimicrobial Resistance Rising Drastically: Studyhttps://phys.org/news/2019-09-global-antibiotic-resistance-food-animals.html... A team of researchers led by Thomas Van Boeckel, SNF Assistant Professor of Health Geography and Policy at ETH Zurich, has recently published a map of antimicrobial resistance in animals in low- and middle-income countries in the journal
Science.The team assembled a large literature database and found out where, and in which animals species resistance occurred for the common foodborne bacteria
Salmonella, E. coli, Campylobacter and Staphylococcus.According to this study, the regions associated with high rates of antimicrobial resistance in animals are northeast China, northeast India, southern Brazil, Iran and Turkey. In these countries, the bacteria listed above are now resistant to a large number of drugs that are used not only in animals but also in human medicine. The highest resistance rates were associated with the antimicrobials most frequently used in animals: tetracyclines, sulphonamides, penicillins and quinolones.
In certain regions, these compounds have almost completely lost their efficacy to treat infections.The researchers introduced a new index to track the evolution of resistance to multiple drugs: the proportion of drugs tested in each region with resistance rates higher than 50%.
Globally, this index has almost tripled for chicken and pigs over the last 20 years. Currently, one third of drugs fail 50% of the time in chicken and one quarter of drugs fail in 50% of the time in pigs.... It is of particular concern that antimicrobial resistance is rising in developing and emerging countries because this is where meat consumption is growing the fastest, while access to veterinary antimicrobials remains largely unregulated.
"Antimicrobial resistance is a global problem. There is little point in making considerable efforts to reduce it on one side of the world if it is increasing dramatically on the other side," the ETH researcher says.
Open Access: T.P. Van Boeckel el al.,
"Global trends in antimicrobial resistance in animals in low- and middle-income countries," Science (2019)
also
https://science.sciencemag.org/content/365/6459/1251